Can genetic risk information for age-related macular degeneration influence motivation to stop smoking A pilot study

Eye

Volumn 26, Issue 1, 2012, Pages 109-118

  Rennie, C A ^a   Stinge, A ^a   King, E A ^b   Sothirachagan, S ^b   Osmond, C ^c   Lotery, A J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

macular degeneration; risk; risk factors; smoking; smoking cessation

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; CIGARETTE SMOKING; CLINICAL ARTICLE; FEMALE; GENETIC RISK; GENETIC SCREENING; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; MALE; MOTIVATION; PILOT STUDY; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION;

EID: 84855821917     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.256     Document Type: Article

References (38)

1. Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Br J Ophthalmol 2003; 87(3): 312-317. (Pubitemid 36307906)
2. Lotery A, Trump D. Progress in defining the molecular biology of age related macular degeneration. Hum Genet 2007; 122(3-4): 219-236. (Pubitemid 47616531)
3. Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 1996; 114(10): 1193-1196. (Pubitemid 26338849)
4. Klaver CC, Assink JJ, Vingerling JR, Hofman A, de Jong PT. Smoking is also associated with age-related macular degeneration in persons aged 85 years and older: the Rotterdam Study. Arch Ophthalmol 1997; 115(7): 945.
5. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993; 137(2): 190-200. (Pubitemid 23083671)
6. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001; 108(4): 697-704. (Pubitemid 32238465)
7. Kelly SP, Thornton J, Lyratzopoulos G, Edwards R, Mitchell P. Smoking and blindness. BMJ 2004; 328(7439): 537-538. (Pubitemid 38316621)
8. Dhubhghaill SS, Cahill MT, Campbell M, Cassidy L, Humphries MM, Humphries P. The pathophysiology of cigarette smoking and age-related macular degeneration. Adv Exp Med Biol 2010; 664: 437-446.
9. Pryor WA, Hales BJ, Premovic PI, Church DF. The radicals in cigarette tar: their nature and suggested physiological implications. Science 1983; 220(4595): 425-427. (Pubitemid 13163438)
10. Bettman JW, Fellows V, Chao P. The effect of cigarette smoking on the intraocular circulation. AMA Arch Ophthalmol 1958; 59(4): 481-488.
11. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45(2): 115-134.
12. Suner IJ, Espinosa-Heidmann DG, Marin-Castano ME, Hernandez EP, Pereira-Simon S, Cousins SW. Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2004; 45(1): 311-317. (Pubitemid 38055703)
13. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Javier NF, Huang GH et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 2010; 128(6): 750-758.
14. Hughes AE, Orr N, Patterson C, Esfandiary H, Hogg R, McConnell V et al. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med 2007; 4(12): e355.
15. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 2007; 125(1): 55-62. (Pubitemid 46072376)
16. Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 2006; 61(3): 157-165. (Pubitemid 44385444)
17. Shuler Jr RK, Hauser MA, Caldwell J, Gallins P, Schmidt S, Scott WK et al. Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism. Arch Ophthalmol 2007; 125(1): 63-67. (Pubitemid 46072377)
18. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006; 78(5): 852-864.
19. Office for National Statistics. Opinions Survey Report No40. Smoking-Related Behaviour and Attitudes. Office for National Statistics, 2008, Available from http://www.ons.gov.uk/ ons/publications/index.html.
20. Sanderson SC, Wardle J. Will genetic testing for complex diseases increase motivation to quit smoking? Anticipated reactions in a survey of smokers. Health Educ Behav 2005; 32(5): 640-653. (Pubitemid 41426745)
21. Sanderson SC, Michie S. Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking. Clin Genet 2007; 71(6): 501-510. (Pubitemid 46831944)
22. Frosch DL, Mello P, Lerman C. Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev 2005; 14(6): 1485-1489. (Pubitemid 40807350)
23. Wright AJ, French DP, Weinman J, Marteau TM. Can genetic risk information enhance motivation for smoking cessation? An analogue study. Health Psychol 2006; 25(6): 740-752. (Pubitemid 44747856)
24. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989; 84(7): 791-799.
25. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991; 86(9): 1119-1127.
26. Asher MK, Martin RA, Rohsenow DJ, MacKinnon SV, Traficante R, Monti PM. Perceived barriers to quitting smoking among alcohol dependent patients in treatment. J Subst Abuse Treat 2003; 24(2): 169-174. (Pubitemid 36547963)
27. Prochaska JO, Diclemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983; 51(3): 390-395.
28. Bidwell G, Sahu A, Edwards R, Harrison RA, Thornton J, Kelly SP. Perceptions of blindness related to smoking: a hospital-based cross-sectional study. Eye 2005; 19(9): 945-948. (Pubitemid 43114973)
29. Moradi P, Thornton J, Edwards R, Harrison RA, Washington SJ, Kelly SP. Teenagers' perceptions of blindness related to smoking: a novel message to a vulnerable group. Br J Ophthalmol 2007; 91(5): 605-607. (Pubitemid 46716526)
30. Sanjay S, Neo HY, Sangtam T, Ku JY, Chau SY, Rostihar AK et al. Survey on the knowledge of age-related macular degeneration and its risk factors among Singapore residents. Clin Experiment Ophthalmol 2009; 37(8): 795-800.
31. Sanderson SC, Wardle J, Michie S. The effects of a genetic information leaflet on public attitudes towards genetic testing. Public Underst Sci 2005; 14(2): 213-224. (Pubitemid 40669876)
32. Carpenter MJ, Strange C, Jones Y, Dickson MR, Carter C, Moseley MA et al. Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency Ann Behav Med 2007; 33(1): 22-28.
33. McBride CM, Bepler G, Lipkus IM, Lyna P, Samsa G, Albright J et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev 2002; 11(6): 521-528. (Pubitemid 34615158)
34. Lerman C, Gold K, Audrain J, Lin TH, Boyd NR, Orleans CT et al. Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol 1997; 16(1): 87-99. (Pubitemid 127465956)
35. Messer K, Trinidad DR, Al Delaimy WK, Pierce JP. Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am J Public Health 2008; 98(2): 317-322. (Pubitemid 351317567)
36. Miller CL, Hill DJ, Quester PG, Hiller JE. Impact on the Australian Quitline of new graphic cigarette pack warnings including the Quitline number. Tob Control 2009; 18(3): 235-237.
37. The NHS Information Centre. Statistics on NHS Stop Smoking Services: England April 2009 to December 2009 (Q3 - Quarterly report) Available from: http:// www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles/nhs- stop-smoking-services/statistics-on-nhs-stop-smoking-services-england-april- 2009-to-december-2009-q3-quarterly-report.
38. Chapman S, Mackenzie R. The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med 2010; 7(2): e1000216.